Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Adeona Pharmaceutical (Exclusive rights of Flupirtine)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

The exclusive US, Canadian and Japanese distribution and marketing rights of flupirtine. Flupirtine is used treat fibromyalgia and is in its phase II of development.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Commercial Services
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 3930 Varsity Drive
  • Ann Arbor, MI 48108
  • United States

Adeona Pharmaceutical (Exclusive rights of Flupirtine) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Adeona Pharmaceutical (Exclusive rights of Flupirtine)‘s full profile, request access.

Request full access to PitchBook

Adeona Pharmaceutical (Exclusive rights of Flupirtine) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Adeona Pharmaceutical (Exclusive rights of Flupirtine)‘s full profile, request access.

Request full access to PitchBook